X. Li

First name
X.
Last name
Li
Liu, X., Jiang, J., Li, D., Horrow, J., Tamada, H., Kahl, A., et al. (2023). Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom. Cardiol Ther. http://doi.org/10.1007/s40119-023-00332-7
Raventós, B., Català, M., Du, M., Guo, Y., Black, A., Inberg, G., et al. (2023). IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5717
Burn, E., Li, X., Delmestri, A., Jones, N., Duarte-Salles, T., Reyes, C., et al. (2022). Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. Nat Commun, 13, 7167. http://doi.org/10.1038/s41467-022-34668-w
Li, X., Burn, E., Duarte-Salles, T., Yin, C., Reich, C., Delmestri, A., et al. (2022). Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. Bmj, 379, e071594. http://doi.org/10.1136/bmj-2022-071594
Burn, E., Li, X., Kostka, K., Stewart, H. M., Reich, C., Seager, S., et al. (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495-510. http://doi.org/10.1002/pds.5419
Li, X., Raventós, B., Roel, E., Pistillo, A., Martinez-Hernandez, E., Delmestri, A., et al. (2022). Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. Bmj, 376, e068373. http://doi.org/10.1136/bmj-2021-068373
Yang, Z., Toh, S., Li, X., Edwards, D., Brayne, C., & Mant, J. (2022). Statin use is associated with lower risk of dementia in stroke patients: a community-based cohort study with inverse probability weighted marginal structural model analysis. Eur J Epidemiol. http://doi.org/10.1007/s10654-022-00856-7
Li, X., Ostropolets, A., Makadia, R., Shoaibi, A., Rao, A., Sena, A. G., et al. (2021). Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. http://doi.org/10.1136/bmj.n1435